Proxy Votes Now

Home › Funds › T. Rowe Price › T. Rowe Price New Horizons Fund, Inc.

T. Rowe Price New Horizons Fund, Inc. (PRJIX) proxy voting record 2025-2026

Fund family: T. Rowe Price · Filed by T. Rowe Price New Horizons Fund, Inc. (CIK 80248) · SEC series S000002106

Share classes and tickers: PRJIX (C000159684), PRNHX (C000005478), TRUZX (C000219323)

“With management” counts the items where the fund’s own filing gives management’s recommendation (FOR or AGAINST): 2,537 with, 13 against, 0 abstentions (not counted as with management). Shareholder proposals: 4 FOR, 8 AGAINST, 0 abstained, by the filing’s own vote-source field.

Compared with T. Rowe Price as a whole

The same two figures as T. Rowe Price’s manager page (244,024 ballot items across 112 funds and accounts), counted the same way for this fund.

2025-2026This fundItemsT. Rowe PriceItems
Voted FOR the board's own proposals (directors, pay, auditor, capital, transactions, fund matters)87.7%2,42093.7%208,710
Backed environmental and social shareholder proposals at US companiesn/a42.6%3,333

Where this fund voted differently from most T. Rowe Price funds

Each ballot item this fund voted is set against the votes of the other T. Rowe Price funds and accounts on the same item (same meeting, same proposal): “most funds” is a strict majority of at least three of them, FOR against AGAINST, WITHHOLD or ABSTAIN, with split votes and items not voted left out. Funds in one family can follow separate voting policies, for example ESG funds, sub-advised funds and funds using pass-through voting.

Voted differently from most T. Rowe Price funds on 54 items (2.4% of the 2,248 items where a comparison was possible).

The most lopsided family majorities first, then the largest companies, then shareholder proposals.
CompanyMeetingItemThis fundMost T. Rowe Price fundsMgmtResult
Loar Holdings Inc.2026-06-023 wordings Election of Raja Bobbili, Alison Bomberg and Margaret (Peg) McGetrick as Class II directors, each to hold office until our annual meeting of stockholders in 2029 and until their successor is duly elected and qualified, or until their earlier death, resignation, or removal: Raja BobbiliWithholdFOR — 9 of 11 T. Rowe Price fundsAgainstPassed (calculated), 98.6% support
Birkenstock Holding Plc2026-04-29Amend Articles of AssociationForAGAINST — 11 of 14 T. Rowe Price fundsFor—
Birkenstock Holding Plc2026-04-29Elect Director Ruth KennedyForAGAINST — 11 of 14 T. Rowe Price fundsFor—
UL Solutions Inc.2026-05-20Election of Directors: Elisabeth TorstadWithholdFOR — 10 of 13 T. Rowe Price fundsAgainst—
UL Solutions Inc.2026-05-20Election of Directors: George A. WilliamsWithholdFOR — 10 of 13 T. Rowe Price fundsAgainstElected, 99.7% support
UL Solutions Inc.2026-05-20Election of Directors: James M. ShannonWithholdFOR — 10 of 13 T. Rowe Price fundsAgainstElected, 99.8% support
UL Solutions Inc.2026-05-20Election of Directors: James P. DolliveWithholdFOR — 10 of 13 T. Rowe Price fundsAgainstElected, 99.6% support
UL Solutions Inc.2026-05-20Election of Directors: Marla C. GottschalkWithholdFOR — 10 of 13 T. Rowe Price fundsAgainstElected, 99.8% support
UL Solutions Inc.2026-05-20Election of Directors: Sally SusmanWithholdFOR — 10 of 13 T. Rowe Price fundsAgainstElected, 99.9% support
Cytokinetics, Incorporated2026-05-272 wordings Election of Class I Directors for terms expiring in 2029: Edward M. Kaye, M.D.WithholdFOR — 15 of 22 T. Rowe Price fundsAgainstPassed (calculated), 97.0% support
Noble Corporation plc2026-04-29Authorization of the Board to Allot Shares without Rights of Pre-Emption.AgainstFOR — 7 of 9 T. Rowe Price fundsAgainstApproved, 81.0% support
Noble Corporation plc2026-04-29Authorization of the Board to Allot Shares.AgainstFOR — 7 of 9 T. Rowe Price fundsAgainst—
Mirion Technologies, Inc.2026-05-13Elect directors for a one-year term: Jody A. MarkopoulosWithholdFOR — 7 of 9 T. Rowe Price fundsAgainstPassed (calculated), 100.0% support
Mirion Technologies, Inc.2026-05-13Elect directors for a one-year term: John W. KuoWithholdFOR — 7 of 9 T. Rowe Price fundsAgainstPassed (calculated), 100.0% support
Mirion Technologies, Inc.2026-05-13Elect directors for a one-year term: Kenneth C. BockhorstWithholdFOR — 7 of 9 T. Rowe Price fundsAgainstPassed (calculated), 100.0% support
Mirion Technologies, Inc.2026-05-13Elect directors for a one-year term: Lawrence D. KingsleyWithholdFOR — 7 of 9 T. Rowe Price fundsAgainstPassed (calculated), 100.0% support
Mirion Technologies, Inc.2026-05-13Elect directors for a one-year term: Robert A. CascellaWithholdFOR — 7 of 9 T. Rowe Price fundsAgainstPassed (calculated), 100.0% support
Mirion Technologies, Inc.2026-05-13Elect directors for a one-year term: Sheila RegeWithholdFOR — 7 of 9 T. Rowe Price fundsAgainstPassed (calculated), 100.0% support
Mirion Technologies, Inc.2026-05-13Elect directors for a one-year term: Steven W. EtzelWithholdFOR — 7 of 9 T. Rowe Price fundsAgainstPassed (calculated), 100.0% support
Mercury Systems, Inc.2025-10-22To elect three Class I directors nominated by the Board of Directors, each to serve for a three-year term, and in each case until their successors have been duly elected and qualified: Howard L. LanceWithholdFOR — 7 of 9 T. Rowe Price fundsAgainst—
Mercury Systems, Inc.2025-10-22To elect three Class I directors nominated by the Board of Directors, each to serve for a three-year term, and in each case until their successors have been duly elected and qualified: Lisa S. DisbrowWithholdFOR — 7 of 9 T. Rowe Price fundsAgainst—
Applied Optoelectronics, Inc.2026-06-04Class I Directors for Election: Che-Wei LinForWITHHOLD — 7 of 9 T. Rowe Price fundsFor—
Applied Optoelectronics, Inc.2026-06-04Class I Directors for Election: Robert (Bob) FlanaganForWITHHOLD — 7 of 9 T. Rowe Price fundsFor—
Patrick Industries, Inc.2026-05-14To elect nine directors to the Board of Directors to serve until the 2027 Annual Meeting of Shareholders: Blake W. AugsburgerWithholdFOR — 7 of 9 T. Rowe Price fundsAgainstElected, 97.4% support
Patrick Industries, Inc.2026-05-14To elect nine directors to the Board of Directors to serve until the 2027 Annual Meeting of Shareholders: Denis G. SuggsWithholdFOR — 7 of 9 T. Rowe Price fundsAgainstElected, 93.5% support
Show all 54
Items 26 to 54.
CompanyMeetingItemThis fundMost T. Rowe Price fundsMgmtResult
Patrick Industries, Inc.2026-05-14To elect nine directors to the Board of Directors to serve until the 2027 Annual Meeting of Shareholders: John A. ForbesWithholdFOR — 7 of 9 T. Rowe Price fundsAgainstElected, 92.6% support
Patrick Industries, Inc.2026-05-14To elect nine directors to the Board of Directors to serve until the 2027 Annual Meeting of Shareholders: Joseph M. CerulliWithholdFOR — 7 of 9 T. Rowe Price fundsAgainstElected, 83.6% support
Patrick Industries, Inc.2026-05-14To elect nine directors to the Board of Directors to serve until the 2027 Annual Meeting of Shareholders: M. Scott WelchWithholdFOR — 7 of 9 T. Rowe Price fundsAgainstElected, 93.4% support
Patrick Industries, Inc.2026-05-14To elect nine directors to the Board of Directors to serve until the 2027 Annual Meeting of Shareholders: Michael A. KitsonWithholdFOR — 7 of 9 T. Rowe Price fundsAgainstElected, 96.3% support
Patrick Industries, Inc.2026-05-14To elect nine directors to the Board of Directors to serve until the 2027 Annual Meeting of Shareholders: Natalie A. BrownWithholdFOR — 7 of 9 T. Rowe Price fundsAgainstElected, 94.3% support
Patrick Industries, Inc.2026-05-14To elect nine directors to the Board of Directors to serve until the 2027 Annual Meeting of Shareholders: Todd M. ClevelandWithholdFOR — 7 of 9 T. Rowe Price fundsAgainstElected, 96.5% support
Peloton Interactive, Inc.2025-12-09Election of Directors: Chris BruzzoForWITHHOLD — 7 of 9 T. Rowe Price fundsForElected, 77.8% support
Root, Inc.2026-06-03To elect three Class III directors, Lawrence Hilsheimer, Alexander Timm and Douglas Ulman, each to hold office until our Annual Meeting of Stockholders in 2029: Lawrence HilsheimerForAGAINST — 7 of 9 T. Rowe Price fundsForElected, 92.8% support
PBF Energy Inc.2026-04-28Election of Directors: Spencer AbrahamAgainstFOR — 7 of 10 T. Rowe Price fundsAgainstElected, 89.4% support
Ambarella, Inc.2026-06-26Election of Directors: D. Jeffrey RichardsonWithholdFOR — 7 of 10 T. Rowe Price fundsAgainstElected, 89.0% support
Ambarella, Inc.2026-06-26Election of Directors: Elizabeth M. SchwartingWithholdFOR — 7 of 10 T. Rowe Price fundsAgainstElected, 80.4% support
Oscar Health, Inc.2026-06-04Election of eight director nominees to serve until the 2027 Annual Meeting of Stockholders: David Alexander PlouffeWithholdFOR — 8 of 12 T. Rowe Price fundsAgainstPassed (calculated), 99.5% support
Oscar Health, Inc.2026-06-04Election of eight director nominees to serve until the 2027 Annual Meeting of Stockholders: Siddhartha SankaranWithholdFOR — 8 of 12 T. Rowe Price fundsAgainstPassed (calculated), 99.7% support
Oscar Health, Inc.2026-06-04Election of eight director nominees to serve until the 2027 Annual Meeting of Stockholders: William (Bill) J. Gassen IIIWithholdFOR — 8 of 12 T. Rowe Price fundsAgainstPassed (calculated), 96.9% support
Bio-Techne Corporation2025-10-30Approve, on an advisory basis, the compensation of our executive officers.ForAGAINST — 8 of 13 T. Rowe Price fundsForApproved, 72.1% support
Dutch Bros Inc.2026-05-13Election of Directors: Todd PenegorForAGAINST — 10 of 17 T. Rowe Price fundsForElected, 91.7% support
Dutch Bros Inc.2026-05-13Election of Directors: Travis BoersmaForAGAINST — 10 of 17 T. Rowe Price fundsForElected, 95.6% support
Marqeta, Inc.2026-06-10To approve an amendment to our Amended and Restated Certificate of Incorporation to provide for officer exculpation as permitted by Delaware law.ForAGAINST — 7 of 11 T. Rowe Price fundsForPassed (calculated), 78.7% support
Marqeta, Inc.2026-06-10To elect the four Class II nominees for director named in the accompanying proxy statement to hold office until the annual meeting of stockholders in 2029 and until their successors have been duly elected and qualified, or until such director's earlier death, resignation, or removal: Judson (Jud) LiForWITHHOLD — 7 of 11 T. Rowe Price fundsForPassed (calculated), 92.2% support
Marqeta, Inc.2026-06-10To elect the four Class II nominees for director named in the accompanying proxy statement to hold office until the annual meeting of stockholders in 2029 and until their successors have been duly elected and qualified, or until such director's earlier death, resignation, or removal: Martha CummingsForWITHHOLD — 7 of 11 T. Rowe Price fundsForPassed (calculated), 82.1% support
Marqeta, Inc.2026-06-10To elect the four Class II nominees for director named in the accompanying proxy statement to hold office until the annual meeting of stockholders in 2029 and until their successors have been duly elected and qualified, or until such director's earlier death, resignation, or removal: Najuma AtkinsonForWITHHOLD — 7 of 11 T. Rowe Price fundsForPassed (calculated), 87.8% support
Marqeta, Inc.2026-06-10To approve, on a non-binding advisory basis, the compensation of our named executive officers.ForAGAINST — 8 of 14 T. Rowe Price fundsForPassed (calculated), 78.5% support
MapLight Therapeutics, Inc.2026-06-23To elect the three Class I Director nominees named in the Proxy Statement to serve until the 2029 annual meeting of our stockholders and until their successors have been duly elected and qualified, or until their earlier death, resignation or removal: Martin BablerForWITHHOLD — 8 of 14 T. Rowe Price fundsFor—
Installed Building Products, Inc.2026-05-19Election of Directors to serve for three-year terms: Robert H. SchottensteinAgainstFOR — 7 of 12 T. Rowe Price fundsAgainstElected, 93.9% support
Xenon Pharmaceuticals Inc.2026-06-02To approve the Corporation's 2026 Equity Incentive Plan;AgainstFOR — 7 of 12 T. Rowe Price fundsAgainstApproved, 68.0% support
Kodiak Sciences Inc.2026-06-02Elect three Class II directors nominated by our board and named in this proxy statement: Charles A. BancroftForWITHHOLD — 8 of 15 T. Rowe Price fundsForElected, 78.7% support
Denali Therapeutics Inc.2026-06-03ELECTION OF DIRECTORS: David Schenkein, M.D.ForWITHHOLD — 8 of 15 T. Rowe Price fundsForElected, 73.5% support
Denali Therapeutics Inc.2026-06-03ELECTION OF DIRECTORS: Jennifer CookForWITHHOLD — 8 of 15 T. Rowe Price fundsForElected, 60.9% support
Impinj, Inc.2026-05-28Election of Directors: Steve SanghiForAGAINST — 7 of 13 T. Rowe Price fundsForElected, 68.1% support

Download all 54 differences (CSV)

Votes against management by sector

The same votes as “with management” above, by the sector of the company voted on. 82.6% of this fund’s 2,550 such votes could be given a sector; the other 444 (17.4%) are at companies without one and are not in the table.

SectorVotesAgainst managementShare
Industrials45651.1%
Health Care43600.0%
Technology37130.8%
Consumer Discretionary34930.9%
Finance21910.5%
Energy11100.0%
Miscellaneous4700.0%
Real Estate4200.0%
Basic Materials3700.0%
Utilities2800.0%
Consumer Staples500.0%
Telecommunications500.0%

What it voted on

Ballot items by the category the filing put first; “against management” as above.
Proposal typeItemsAgainst management
Director Elections1,6550
Audit-related2950
Say-on-Pay2630
Compensation1180
Corporate Governance1049
Capital Structure890
Extraordinary Transactions230
Other100
Shareholder Rights and Defenses80
Other Social Issues73

Its largest holdings’ meetings

Position = shares voted × a recent share price, for US-listed shares of companies with a page on this site; an estimate for ranking only.

CompanyMeetingEst. positionItemsAgainst mgmt
RBC Bearings IncorporatedSeptember 4, 2025$348M60
Natera, Inc.June 11, 2026$290M80
Lattice Semiconductor CorporationMay 1, 2026$272M100
argenx SENovember 18, 2025$270M10
Kymera Therapeutics, Inc.June 24, 2026$245M60
Guardant Health, Inc.June 17, 2026$223M50
Samsara Inc.July 29, 2025$206M110
argenx SEMay 6, 2026$206M120

Notable votes against management

MeetingCompanyProposalFundMgmt
May 6, 2026Entegris, Inc.Stockholder Proposal: Providing stockholders the right to call special meetings of stockholders. Shareholder proposalAgainstFor
July 23, 2025Booz Allen Hamilton Holding CorporationVote on a stockholder proposal regarding a report on political spending. Shareholder proposalAgainstFor
May 20, 2026Reliance, Inc.To consider a stockholder proposal requiring any director who fails to receive a majority vote to leave the board of directors within nine months. Shareholder proposalAgainstFor
June 15, 2026Datadog, Inc.The stockholder proposal, if properly presented at the Annual Meeting, requesting the adoption of a simple majority voting provision. Shareholder proposalForAgainst
June 3, 2026Power Integrations, Inc.To consider, if properly presented at the Annual Meeting, a stockholder proposal related to the separation of the office of Chairman of the Board and the office of Chief Executive Officer. Shareholder proposalAgainstFor
May 11, 2026MKS Inc.A shareholder proposal to reduce the threshold percentage of shareholders required to call a special meeting of shareholders from 40% to 10%, if properly presented at the meeting. Shareholder proposalAgainstFor
April 29, 2026Huntington Ingalls Industries, Inc.Stockholder proposal requesting an annual report on the Company's political spending. Shareholder proposalAgainstFor
April 29, 2026Huntsman CorporationStockholder proposal requesting an independent board chair policy. Shareholder proposalAgainstFor
June 15, 2026HubSpot, Inc.A stockholder proposal to change the Company's Sixth Amended and Restated Bylaws to allow 10% holders of the Company's stock the ability to call a special meeting; and Shareholder proposalForAgainst
June 16, 2026Five Below, Inc.Shareholder proposal requesting that provisions in the Company's governance documents requiring greater than a simple majority shareholder vote be changed to a simple majority vote standard. Shareholder proposalForAgainst
May 1, 2026Zions Bancorporation, N.A.To consider a shareholder proposal regarding "Report on Risks from Misalignment Between Company Policies and Customer Base." Shareholder proposalAgainstFor
May 20, 2026Hyatt Hotels CorporationStockholder proposal requesting the issuance of a report analyzing whether Hyatt could disclose its overall plastics use. Shareholder proposalForAgainst

Contested meetings

Meetings with a proxy contest or competing nominees (1 in 2025-2026), and how the fund voted the items on its ballot.

Search this fund’s votes by company

2,573 ballot items at 307 meetings in 2025-2026. Download all votes (CSV)

Recent notable votes

Recent votes against management’s recommendation at large companies.

About this fund’s record

In the 2025-2026 proxy season, T. Rowe Price New Horizons Fund, Inc. (PRJIX) voted at 307 shareholder meetings of 299 companies, on 2,573 ballot items in all. Where management made a recommendation, the fund followed it on 99.5% of the items and voted against it 13 times. Its most frequent area of disagreement was corporate governance (9 of its votes against management). It voted on 12 shareholder proposals. It voted FOR the board's own proposals less often than T. Rowe Price's funds as a whole (87.7% against 93.7%). It voted differently from most T. Rowe Price funds on 54 items. 1 of its meetings was contested.

About this page

Every figure is derived from the fund’s own Form N-PX filings with the SEC, read item by item: one ballot item is the fund’s vote on one proposal at one meeting, and an item filed twice in the season is counted once. Percentages count items, never shares. A season is published only with at least 250 ballot items at 15 meetings. Built November 18, 2026; the family figures are those of T. Rowe Price’s manager page. The interactive database shows the same votes company by company, with every other fund that voted.